Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fluid derived from aloe plant prolongs life after hemorrhagic shock in animal study

27.07.2004


Results suggest the fluid could increase survival in trauma patients and wounded soldiers



A novel resuscitation fluid derived from aloe vera that was developed by researchers at the University of Pittsburgh’s McGowan Institute for Regenerative Medicine has the potential to save the lives of patients with massive blood loss, according to results of an animal study published in the August edition of the medical journal Shock. The findings could have a significant impact on the treatment of hemorrhagic shock caused by both civilian and military trauma.
In a rodent model of hemorrhagic shock, animals that were given a very small amount of the fluid, an aloe vera-derived drag reducing polymer (DRP), had significantly longer survival time and increased systemic whole body oxygen consumption, even in the absence of resuscitation with blood or other fluids, compared to animals that did not receive DRP.

"We hope this fluid will offer a viable solution to a significant problem, both on and off the battlefield. Typically, hemorrhagic shock is treated by controlling ongoing bleeding and restoring blood volume by infusing a lactate solution and packed red blood cells. Soldiers wounded in combat often lose significant amounts of blood, and there is no practical way to replace the necessary amount of blood fast enough on the front lines. When this happens, there is inadequate perfusion of the organs which quickly leads to a cascade of life-threatening events," said senior author Mitchell P. Fink, M.D., professor and chair, department of critical care medicine and Watson Professor of Surgery at the University of Pittsburgh School of Medicine.



"Medics would need only to carry a small amount of this solution, which could feasibly be administered before the soldier is evacuated to a medical unit or facility," he added.

The central ingredient of Pitt’s resuscitation fluid comes from the slick substance inside the leaves of the aloe vera plant. A so-called mucilage, it is rich in polysaccharides and has a high molecular mass and specific "visco-elastic" properties that allow it to reduce resistance to turbulent flow when added to a fluid at minute concentrations.

"As a drag reducing polymer, it may provide better diffusion of oxygen molecules from red blood cells to tissues because of its ability to better mix in the plasma surrounding red blood cells," explained Marina Kameneva, Ph.D., research associate professor of surgery and bioengineering, University of Pittsburgh, and director of the Artificial Blood Program at the McGowan Institute, who developed the fluid and has been researching its potential for the past several years.

In the current study, lead by Carlos A. Macias, M.D., a visiting research associate in the department of critical care medicine at the University of Pittsburgh’s School of Medicine, five of 10 rats that were injected with a small amount of a normal saline solution survived four hours after hemorrhagic shock. Of the animals treated with a same amount of saline and the aloe-derived DRP, eight of 10 survived. The animals treated with DRP also fared better in another experiment involving more severe blood loss; five of 15 survived the two-hour observation period, compared to one of 14 treated with saline solution alone. Seven animals receiving no treatment all died within 35 minutes.

According to the Department of Health and Human Services, trauma is the leading cause of death for those under the age of 40. In the United States, traumatic injuries result in approximately 150,000 deaths per year; complications resulting from the loss of large amounts of blood account for almost half these deaths.

In addition to Drs. Fink, Kameneva and Macias, authors of the study are Jyrki J. Tenhunen, M.D., Ph.D., visiting research associate in the department of critical care medicine at the University of Pittsburgh’s School of Medicine; and Juan-Carlos Puyana, M.D., associate professor of critical care medicine and surgery at Pitt and critical care director of the trauma/surgery intensive care units at the University of Pittsburgh Medical Center.

Jocelyn Uhl | EurekAlert!
Further information:
http://www.upmc.edu

More articles from Studies and Analyses:

nachricht Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center

nachricht Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>